Impaired function and delayed regeneration of dendritic cells in COVID-19
코로나19에서 손상된 수지상 세포의 기능 장애 및 재생 지연
Clinical Trial
[키워드] accompanied
activated
acute illness
acute phase
adaptive
Adaptive immune response
adaptive immune responses
alteration
analyzed
antibody
antibody-secreting cells
antiviral immunity
Blood
CD14
CD14+ cell
CD14+ cells
CD163
CD4
CD86
Cell
cells
circulating
classical monocyte
classical monocytes
Clinical management
consequence
contribute
correlated
COVID-19
COVID-19 patient
COVID-19 patients
COVID-19 severity
DCs
dendritic cell
dendritic cells
Depletion
disease
disease severity
downregulation
dysregulated
dysregulated innate immune response
expansion
follicular
Frequency
functional
healthy controls
helper cells
HLADR
hospitalized COVID-19 patient
Host immune response
identify
immune responses
immunopathology
Impaired
impairment
Increased
Inflammatory response
Inflammatory responses
inhibitory
innate immune response
long-lasting
manifestation
Mild
modulation
monocyte
monocyte subsets
Monocytes
naïve
Patient
PD-L1
persistent
recognize
reduced
reduction
regeneration
SARS-COV-2 infection
Secondary infection
secondary infections
severe disease
stimulate
subpopulation
subset
susceptibility
systemic inflammation
T cell
T cells
T follicular helper cells
the disease
therapy
these cell
These cells
Trigger
upregulation
Viral
viral infection
viral infections
[DOI] 10.1371/journal.ppat.1009742 PMC 바로가기 [Article Type] Clinical Trial
[DOI] 10.1371/journal.ppat.1009742 PMC 바로가기 [Article Type] Clinical Trial